Centene vs Molina Healthcare
CNC and MOH side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CNC and MOH compare
Centene is the larger company, worth 3.2 times as much as Molina Healthcare ($33.8B against $10.7B).
Centene grew revenue faster over the last twelve months (13.9% versus 2.6% for Molina Healthcare).
Molina Healthcare keeps more of each dollar of sales as profit, with a net margin of −0.02% compared with −2.5% at Centene.
Centene scores higher on the StockData Score (6 against 5 for Molina Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CNC | MOH |
|---|---|---|
| Size and price | ||
| Market cap | $33.8B | $10.7B |
| Share price | $68.45 | $204.78 |
| Change, 1 year | 83.3% | 27.8% |
| Change, 5 years | −7.7% | −32.7% |
| Beta (5Y) | 0.50 | 0.25 |
| Employees | 61K | 19K |
| StockData Score | ||
| Total score | 6 (better) | 5 |
| Valuation score | 2 (better) | 1 |
| Growth score | 2 | 2 |
| Performance score | 0 | 0 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× (better) | 0.2× |
| P/B | 1.5× (better) | 2.6× |
| EV/EBITDA | – | 14.9× |
| P/FCF | 3.8× (better) | 39.4× |
| FCF yield | 26.5% (better) | 2.5% |
| Growth | ||
| Revenue growth (TTM) | 13.9% (better) | 2.6% |
| Revenue growth, 5Y average | 11.9% | 18.5% (better) |
| Net income growth (TTM) | −348% | −101% (better) |
| EPS growth (TTM) | −358% | −101% (better) |
| EPS growth, 5Y average | – | −4.5% |
| Profitability | ||
| Gross margin | 8.0% | 12.6% (better) |
| Operating margin | −2.8% | 0.46% (better) |
| Net margin | −2.5% | −0.02% (better) |
| FCF margin | 4.4% (better) | 0.61% |
| Return on equity | −20.4% | −0.16% (better) |
| Return on invested capital | −22.7% | – |
| Financial health | ||
| Debt / equity | 0.71 (better) | 0.90 |
| Net debt / EBITDA | – | −13.87 |
| Interest coverage | −8.6× | 1.0× (better) |
| Current ratio | 1.15 | 1.68 (better) |
| Altman Z-score | 2.83 | 4.08 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | −0.01% | 4.7% (better) |
| Shareholder yield | −0.01% | 4.7% (better) |
| Ownership | ||
| Held by institutions | 98.8% | 108% |
| Held by insiders | 0.79% | 1.5% |
| Insider net buying, 12 months | −$14.6M | −$3.5M (better) |
| Superinvestors holding | 3 (better) | 2 |
| Short interest, % of float | 2.1% | 5.6% |
Go deeper
- CNC stock overview
- CNC income statement
- CNC valuation and score
- MOH stock overview
- MOH income statement
- MOH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.